Beijing News Express (Reporter Xu Wen) As one of the parallel forums of the Zhongguancun Forum, the Global Science, Life and Health Forum was held in Beijing today (September 18).

The Minister of Science and Technology Wang Zhigang revealed in his speech that currently 11 vaccines in China have entered clinical trials, 4 of which have entered phase III clinical trials.

  Wang Zhigang introduced that since the outbreak of the epidemic, Chinese scientific and technological circles and scientific researchers have devoted themselves to scientific research on epidemic prevention and control.

At the beginning of the epidemic, the Chinese government established a multi-departmental and cross-departmental coordination mechanism, adhered to the combination of scientific research and clinical treatment, focusing on drug screening, vaccine development, detection technology, viral etiology and epidemiology, and animal models. The key direction, focusing on the front-line needs of anti-epidemic, quickly screened and evaluated a batch of effective therapeutic drugs and treatment methods, and completed the development of nucleic acid detection and antibody detection reagents in a short time.

  At the same time, China is advancing in parallel the research and development of 5 technical routes including inactivated vaccines, adenovirus vector vaccines, recombinant protein vaccines, nucleic acid vaccines, and attenuated influenza vaccines. At present, 11 vaccines have entered the clinical trial stage, 4 of which have entered the third stage. Phase clinical trials.

  Wang Zhigang said that the current new crown pneumonia epidemic is still spreading globally and has not been fully controlled. With the arrival of this autumn and winter, there is still the possibility of a rebound, and the epidemic prevention and control situation is still severe.

Viruses know no borders. We need to help each other in the same boat to tide over the difficulties together.

  Wang Zhigang said that the Chinese science and technology community will continue to adhere to the combination of scientific research and epidemic prevention and control, improve the public health scientific research system, carry out international scientific and technological cooperation, share scientific research results and anti-epidemic experience with countries around the world, and implement the new crown vaccine as a global public product. Solemn promise; promote international dialogue and exchanges on epidemic prevention and control policies, and promote the establishment of a global scientific and technological cooperation network for epidemic prevention and control.